Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-Seq of mice Bone Marrow Mononuclear Cells (BMMCs) under IL-3 + IL-33 or Dexamethasone (Dex) or transforming growth factor beta-1 (TGFb) tretament

ABSTRACT: Comparison of gene expression after treatment of mice Bone Marrow Mononuclear Cells (BMMCs) with either IL-3 or IL-3+IL-33 or IL-3+Dex or IL-3+TGFb.

ORGANISM(S): Mus musculus

PROVIDER: GSE163065 | GEO | 2021/10/27

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-Seq of mice Bone Marrow Mononuclear Cells (BMMCs) under IL-3 + IL-33 or Dexamethasone (Dex) or transforming growth factor beta-1 (TGFb) tretament

Project description:RNA-Seq of mice Bone Marrow Mononuclear Cells (BMMCs) under IL-3 + IL-33 or Dexamethasone (Dex) or transforming growth factor beta-1 (TGFb) tretament

| PRJNA684588 | ENA

Effect of Dexamethasone, IL-1B and Dex+IL-1B on gene expression in Th17 cells

Project description:Effect of Dexamethasone, IL-1B and Dex+IL-1B on gene expression in Th17 cells

| PRJNA961106 | ENA

Bone marrow-derived mast cells +- IL-33 48h

Project description:Mast cells are tissue resident granulocytes which are most abundant at the interface between tissues and the external environment, such as around blood vessels, in the skin or mucosal surfaces in the lungs and gut. Pathologically they are involved in allergic reactions and anaphylaxis, however they may also play protective roles in responses to some infections, particularly to pathogenic helminths. Mast cells also express high levels of the IL-33 receptor, which like TLRs, activates Myd88 dependent signalling pathways to drive de novo cytokine production in mast cells.IL-33 is a member of the IL-1 family known to stimulate a number of immune cell types including mast cells. IL-33 is a strong activator of de novo cytokine production in mast cells without inducing degranulation, although it has also been shown to synergise with other signals to promote degranulation. Bone Marrow-Derived Mast cells (BMMCs) were cultured as described previously [27]. Briefly, bone marrow was flushed in PBS and the cells pelleted by centrifugation. Cells were cultured at 1 million cells per ml in RPMI 1640 supplemented with 10% FBS (Biosera/Labtech), 5 mM l‐Glutamine (GIBCO Life Technologies), 100 U/ml Penicillin (GIBCO Life Technologies), 100 μg/ml Streptomycin (GIBCO Life Technologies), 25 mM HEPES (Lonza), 1 mM sodium pyruvate (Lonza), 1X nonessential amino acids (Lonza), 50 μM 2‐mercaptoethanol and 30 ng/ml IL‐3 (PeproTech). Cells were passaged twice per week and used between passage 12 and 16. 4 independent BMMC cultures were either stimulated with 10 ng/ml IL-33 for 48 hours or left unstimulated, followed by single shot LC-MS analysis.

2023-03-11 | PXD033759 | Pride

Microarray analysis of naïve bone marrow derived mast cells (BMMCs) and BMMCs 4hr post ionomycin activation

Project description:Gene expression profile of BMMCs four hours post activation with ionomycin compared to naive BMMCs.

2022-09-27 | GSE207235 | GEO

Gene induction by Dex, IL-9 and CCL-1 in BW5147 mouse T cell lymphoma

Project description:The aim of this work was to determine the genes and mechanisms involved in IL-9- and CCL1-mediated protection against glucocorticoid-induced apoptosis. We made the hypothesis that the expression of the really critical mediators could be regulated in a reciprocal way by Dex on the one hand and anti-apoptotic cytokines such as IL-9 and CCL1 on the other hand.Therefore, we performed a comprehensive study of the genes expressed by BW5147 cells stimulated with or without Dex, IL-9 and CCL1, taking advantage of the Affymetrix microarray technology. Keywords: cytokine and dexamethasone stimulation

2011-05-25 | GSE13823 | GEO

Effect of Dexamethasone, IL-1B and Dex+IL-1B on gene expression in Th17 cells

Project description:To investigate the response of Th17 cells to IL-1B and Dexamethasone, and the ability of IL-B to alter the steroid-responsiveness of Th17 cells

2024-04-30 | GSE230417 | GEO

Gene induction by Dex, IL-9 and CCL-1 in BW5147 mouse T cell lymphoma

2011-05-25 | E-GEOD-13823 | biostudies-arrayexpress

Transcriptomic response of ginsenoside Rc (gRc) in C2C12 myotube under dexamethasone (DEX) treatment

Project description:This study aimed to observe the effect of gRc on C2C12 myotubes under resting state and DEX treatment to indentify the transcript expression induced by gRc in the C2C12 myotubes.

2024-03-20 | GSE261787 | GEO

Gene expression analysis of murine wt and Nbeal2 -/- bone marrow derived mast cells (BMMCs) w/o IL-33 treatment

Project description:Gene expression analysis of murine wt and Nbeal2 -/- bone marrow derived mast cells (BMMCs) w/o IL-33 treatment

| PRJNA937170 | ENA

Jakyak-gamcho-tang ameliorates dexamethasone (DEX)-induced muscle atrophy and muscle dysfunction [Gastrocnemius and Soleus]

Project description:Jakyak-gamcho-tang (JGT) is a herbal medicine that has been traditionally prescrived for pain control including muscular pain. Muscle atrophy is a disease that is characterized with a gradual muscle loss. Muscle atrophy is clearly observed in experimental animals that receive a repeated high-dose of an artificial glucocorticoid, dexamethasone (DEX). This transcriptome analysis aims to investigate the changes in global gene expression profiles in gastrocnemius (GA) and soleus (SO) muscle tissues from mice with DEX-induced muscle atrophy in the presence or absence of JGT co-treatment.

2023-03-21 | GSE227495 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data